Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Korner

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
The European Journal of Neuroscience|November 15, 2006
Mechanism of progesterone neuroprotection of rat cerebellar Purkinje cells following oxygen-glucose deprivationA Ardeshiri, M H Kelley, I P Korner, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1984
Total, and organ-specific, noradrenaline plasma kinetics in essential hypertensionM Esler, G Jennings, P Korner, et al.
Circulation Research|June 1, 1980
Norepinephrine kinetics in patients with idiopathic autonomic insufficiencyM Esler, G Jackman, D Kelleher, et al.
Clinical Science (London, England : 1979)|December 1, 1980
Determination of noradrenaline uptake, spillover to plasma and plasma concentration in patients with essential hypertensionM Esler, G Jackman, P Leonard, et al.
Life Sciences|October 22, 1979
Determination of norepinephrine apparent release rate and clearance in humansM Esler, G Jackman, A Bobik, et al.
Hypertension (Dallas, Tex. : 1979)|January 1, 1988
Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnoverM Esler, G Jennings, P Korner, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 1981
Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patientsM Esler, G Jackman, A Bobik, et al.
Clinical and Experimental Pharmacology & Physiology|September 1, 1980
Assessment of neuronal uptake of noradrenaline in humans: defective uptake in some patients with essential hypertensionM Esler, P Leonard, D Kelleher, et al.
Clinical and Experimental Pharmacology & Physiology|September 1, 1981
Differing noradrenaline kinetics in essential hypertension and depressive illness, two diseases in which the plasma concentration of noradrenaline is sometimes elevatedM Esler, J Turbott, R Schwarz, et al.
The American Journal of Psychiatry|March 1, 1995
Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholicsH R Kranzler, J A Burleson, P Korner, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
The European Journal of Neuroscience|November 15, 2006
Mechanism of progesterone neuroprotection of rat cerebellar Purkinje cells following oxygen-glucose deprivationA Ardeshiri, M H Kelley, I P Korner, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1984
Total, and organ-specific, noradrenaline plasma kinetics in essential hypertensionM Esler, G Jennings, P Korner, et al.
Circulation Research|June 1, 1980
Norepinephrine kinetics in patients with idiopathic autonomic insufficiencyM Esler, G Jackman, D Kelleher, et al.
Clinical Science (London, England : 1979)|December 1, 1980
Determination of noradrenaline uptake, spillover to plasma and plasma concentration in patients with essential hypertensionM Esler, G Jackman, P Leonard, et al.
Life Sciences|October 22, 1979
Determination of norepinephrine apparent release rate and clearance in humansM Esler, G Jackman, A Bobik, et al.
Hypertension (Dallas, Tex. : 1979)|January 1, 1988
Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnoverM Esler, G Jennings, P Korner, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 1981
Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patientsM Esler, G Jackman, A Bobik, et al.
Clinical and Experimental Pharmacology & Physiology|September 1, 1980
Assessment of neuronal uptake of noradrenaline in humans: defective uptake in some patients with essential hypertensionM Esler, P Leonard, D Kelleher, et al.
Clinical and Experimental Pharmacology & Physiology|September 1, 1981
Differing noradrenaline kinetics in essential hypertension and depressive illness, two diseases in which the plasma concentration of noradrenaline is sometimes elevatedM Esler, J Turbott, R Schwarz, et al.
The American Journal of Psychiatry|March 1, 1995
Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholicsH R Kranzler, J A Burleson, P Korner, et al.
Pageof 5